Shannon Thyme Klinger's most recent trade in Moderna Inc was a trade of 1,139 Common Stock done . Disclosure was reported to the exchange on March 7, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,139 | 26,163 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,139 | 1,139 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.30 per share. | 07 Mar 2025 | 551 | 25,612 (0%) | 0% | 34.3 | 18,899 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 55,543 | 55,543 | - | - | Stock Option (Right to Buy) | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 34,655 | 34,655 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 329 | 25,184 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 329 | 2,630 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 233 | 24,968 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 233 | 931 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.09 per share. | 28 Feb 2025 | 160 | 25,024 (0%) | 0% | 31.1 | 4,974 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.09 per share. | 28 Feb 2025 | 113 | 24,855 (0%) | 0% | 31.1 | 3,513 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 3,094 | 24,861 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 3,094 | 9,283 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 2,653 | 0 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 2,653 | 26,018 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 1,496 | 23,365 (0%) | 0% | 33.6 | 50,236 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 27 Feb 2025 | 1,283 | 24,735 (0%) | 0% | 33.6 | 43,083 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 2,047 | 22,493 (0%) | 0% | 0 | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.93 per share. | 12 Feb 2025 | 1,068 | 21,425 (0%) | 0% | 30.9 | 33,033 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,138 | 2,278 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,138 | 20,975 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 44.68 per share. | 06 Dec 2024 | 529 | 20,446 (0%) | 0% | 44.7 | 23,637 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 188,761 | 188,761 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 232 | 1,164 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 232 | 19,949 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 43.29 per share. | 02 Dec 2024 | 112 | 19,837 (0%) | 0% | 43.3 | 4,849 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 2,652 | 2,653 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 2,652 | 21,135 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 42.79 per share. | 27 Nov 2024 | 1,418 | 19,717 (0%) | 0% | 42.8 | 60,675 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 329 | 18,483 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 329 | 2,959 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 1,139 | 3,416 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 1,139 | 18,705 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 73.57 per share. | 06 Sep 2024 | 551 | 18,154 (0%) | 0% | 73.6 | 40,539 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 233 | 1,396 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 233 | 17,680 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 76.99 per share. | 30 Aug 2024 | 114 | 17,566 (0%) | 0% | 77.0 | 8,777 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 329 | 3,288 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2024 | 329 | 17,609 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 78.02 per share. | 28 Aug 2024 | 162 | 17,447 (0%) | 0% | 78.0 | 12,640 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 2,652 | 5,305 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 2,652 | 18,599 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 79.39 per share. | 27 Aug 2024 | 1,319 | 17,280 (0%) | 0% | 79.4 | 104,722 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 9,108 | 21,125 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 9,108 | 0 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 148.09 per share. | 07 Jun 2024 | 5,178 | 15,947 (0%) | 0% | 148.1 | 766,785 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 1,139 | 4,555 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 1,139 | 12,017 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 232 | 1,629 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 232 | 11,000 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 140.72 per share. | 31 May 2024 | 122 | 10,878 (0%) | 0% | 140.7 | 17,168 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 328 | 3,617 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 328 | 10,951 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 144.50 per share. | 28 May 2024 | 183 | 10,768 (0%) | 0% | 144.5 | 26,444 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 2,652 | 11,919 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 2,652 | 7,957 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 162.47 per share. | 24 May 2024 | 1,296 | 10,623 (0%) | 0% | 162.5 | 210,566 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 1,138 | 9,811 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 1,138 | 5,694 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 99.05 per share. | 07 Mar 2024 | 544 | 9,267 (0%) | 0% | 99.1 | 53,884 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 233 | 1,861 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 233 | 8,790 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 94.34 per share. | 01 Mar 2024 | 117 | 8,673 (0%) | 0% | 94.3 | 11,038 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 1,315 | 9,227 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 1,315 | 3,945 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 94.57 per share. | 28 Feb 2024 | 670 | 8,557 (0%) | 0% | 94.6 | 63,363 | Common Stock |
Moderna Inc | Shannon Klinger Thyme | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 60,216 | 60,216 | - | - | Stock Option (Right to Buy) | |
Moderna Inc | Klinger Thyme Shannon | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 23,635 | 23,635 | - | - | Stock Option (Right to Buy) | |
Moderna Inc | Klinger Thyme Shannon | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 12,377 | 12,377 | - | - | Restricted Stock Units | |
Moderna Inc | Klinger Thyme Shannon | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 10,609 | 10,609 | - | - | Restricted Stock Units | |
Moderna Inc | Thyme Klinger Shannon | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 1,139 | 6,832 | - | - | Restricted Stock Units | |
Moderna Inc | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 1,139 | 8,475 (0%) | 0% | - | Common Stock | |
Moderna Inc | Klinger Shannon Thyme | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 79.09 per share. | 07 Dec 2023 | 563 | 7,912 (0%) | 0% | 79.1 | 44,525 | Common Stock |
Moderna Inc | Klinger Thyme Shannon | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 232 | 7,447 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 232 | 2,094 | - | - | Restricted Stock Units | |
Moderna Inc | Thyme Klinger Shannon | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 79.32 per share. | 01 Dec 2023 | 111 | 7,336 (0%) | 0% | 79.3 | 8,804 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 1,139 | 9,109 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 1,139 | 7,081 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 124.09 per share. | 07 Jun 2023 | 565 | 6,516 (0%) | 0% | 124.1 | 70,111 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 232 | 2,559 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 232 | 6,052 (0%) | 0% | - | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 130.33 per share. | 01 Jun 2023 | 110 | 5,942 (0%) | 0% | 130.3 | 14,336 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 1,138 | 10,248 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 1,138 | 6,381 (0%) | 0% | 0 | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 141.51 per share. | 07 Mar 2023 | 561 | 5,820 (0%) | 0% | 141.5 | 79,388 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 930 | 2,791 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 930 | 5,702 (0%) | 0% | 0 | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 136.43 per share. | 01 Mar 2023 | 459 | 5,243 (0%) | 0% | 136.4 | 62,623 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 20,040 | 20,040 | - | - | Stock Option (Right to Buy) | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 5,260 | 5,260 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 1,139 | 11,386 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 1,139 | 5,262 (0%) | 0% | 0 | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 179.15 per share. | 07 Dec 2022 | 490 | 4,772 (0%) | 0% | 179.1 | 87,783 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2022 | 1,138 | 12,525 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2022 | 1,138 | 4,427 (0%) | 0% | 0 | Common Stock | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 137.44 per share. | 07 Sep 2022 | 478 | 3,949 (0%) | 0% | 137.4 | 65,698 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 4,554 | 13,663 | - | - | Restricted Stock Units | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 140.00 per share. | 07 Jun 2022 | 4,554 | 4,554 (0%) | 0% | 140 | 637,560 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 148.12 per share. | 07 Jun 2022 | 1,265 | 3,289 (0%) | 0% | 148.1 | 187,371 | Common Stock |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 15,091 | 15,091 | - | - | Stock Option (Right to Buy) | |
Moderna Inc | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 3,721 | 3,721 | - | - | Restricted Stock Units |